These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24644274)

  • 1. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.
    Zemanick ET; Emerson J; Thompson V; McNamara S; Morgan W; Gibson RL; Rosenfeld M;
    Pediatr Pulmonol; 2015 Jan; 50(1):42-8. PubMed ID: 24644274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Pulm Med; 2017 Jul; 17(1):106. PubMed ID: 28750627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study.
    Maliniak ML; Stecenko AA; McCarty NA
    J Cyst Fibros; 2016 May; 15(3):350-6. PubMed ID: 26610860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
    Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
    Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.
    Sanders DB; Emerson J; Ren CL; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1170-6. PubMed ID: 26288390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway infections as a risk factor for Pseudomonas aeruginosa acquisition and chronic colonisation in children with cystic fibrosis.
    Mésinèle J; Ruffin M; Guillot L; Boëlle PY; Corvol H
    J Cyst Fibros; 2023 Sep; 22(5):901-908. PubMed ID: 37422431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.
    Hubert D; Réglier-Poupet H; Sermet-Gaudelus I; Ferroni A; Le Bourgeois M; Burgel PR; Serreau R; Dusser D; Poyart C; Coste J
    J Cyst Fibros; 2013 Sep; 12(5):497-503. PubMed ID: 23291443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
    Cogen J; Emerson J; Sanders DB; Ren C; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Pediatr Pulmonol; 2015 Aug; 50(8):763-70. PubMed ID: 26061914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
    Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL;
    Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis.
    Muhlebach MS; Heltshe SL; Popowitch EB; Miller MB; Thompson V; Kloster M; Ferkol T; Hoover WC; Schechter MS; Saiman L;
    Ann Am Thorac Soc; 2015 Jun; 12(6):864-71. PubMed ID: 25745825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
    Mayer-Hamblett N; Kronmal RA; Gibson RL; Rosenfeld M; Retsch-Bogart G; Treggiari MM; Burns JL; Khan U; Ramsey BW;
    Pediatr Pulmonol; 2012 Feb; 47(2):125-34. PubMed ID: 21830317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
    Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
    Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis.
    Heltshe SL; Khan U; Beckett V; Baines A; Emerson J; Sanders DB; Gibson RL; Morgan W; Rosenfeld M
    J Cyst Fibros; 2018 May; 17(3):341-347. PubMed ID: 29110966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of meteorological and geographical factors and risk of initial Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
    Psoter KJ; DE Roos AJ; Wakefield J; Mayer JD; Bryan M; Rosenfeld M
    Epidemiol Infect; 2016 Apr; 144(5):1075-83. PubMed ID: 26449886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa.
    Tingpej P; Elkins M; Rose B; Hu H; Moriarty C; Manos J; Barras B; Bye P; Harbour C
    Respirology; 2010 Aug; 15(6):923-9. PubMed ID: 20573059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort.
    Rosenfeld M; Emerson J; McNamara S; Thompson V; Ramsey BW; Morgan W; Gibson RL;
    J Cyst Fibros; 2012 Sep; 11(5):446-53. PubMed ID: 22554417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.
    Wells JM; Farris RF; Gosdin TA; Dransfield MT; Wood ME; Bell SC; Rowe SM
    Lancet Respir Med; 2016 Aug; 4(8):636-645. PubMed ID: 27298019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Intensity of Antipseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Children With Cystic Fibrosis and Newly Acquired Pseudomonas Aeruginosa.
    Cogen JD; Onchiri FM; Hamblett NM; Gibson RL; Morgan WJ; Rosenfeld M
    Clin Infect Dis; 2021 Sep; 73(6):987-993. PubMed ID: 33693586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.
    Razvi S; Quittell L; Sewall A; Quinton H; Marshall B; Saiman L
    Chest; 2009 Dec; 136(6):1554-1560. PubMed ID: 19505987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.